New evidence
Okra lowered fasting blood glucose by 40 mg/dL in nine RCTs — but only in people already diagnosed with diabetes or prediabetes, and the same meta-analysis found no effect on triglycerides, blood pressure, or body weight.
This is the first solid, pooled evidence that okra may help with blood sugar control in a clinical population, but the effect size comes from moderate-quality evidence and only three studies have looked at this specific pairing — so it's interesting, not definitive.
A meta-analysis of nine randomized trials found that consuming up to 3,000 mg/day of okra (as a supplement or extract) led to a large drop in fasting blood glucose (about 40 mg/dL on average) and also improved HbA1c, total cholesterol, and LDL in people with prediabetes or diabetes. However, the evidence strength is still moderate — only three studies have tested okra specifically for blood glucose — and many other cardiometabolic markers (triglycerides, HDL, blood pressure, body weight) did not budge.
Where this fits in the evidence
Pillser has synthesized 3 studies on Okra for Reduced Fasting Blood Glucose Levels — overall evidence strength: Moderate.
Across all 3 studies, okra supplementation consistently shows beneficial and statistically significant reductions in fasting blood glucose levels. Effect sizes range from moderate to large, with mean reductions of approximately 15–40 mg/dL reported in meta-analyses of clinical populations (pre-diabetes and type 2 diabetes). The most-studied dose is ≤3,000 mg/day, but median study duration was not consistently reported.
The study
- Systematic Review
- 2024-12-12
- Frontiers in nutrition
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.